We are live on
!
Find out more
KBC Group Portfolio holdings
AUM
$39.9B
1-Year Est. Return
29.7%
This Fund
S&P 500
This Quarter
Est. Return
+10.6%
1 Year Est. Return
+29.7%
3 Year Est. Return
+99.77%
5 Year Est. Return
+133.11%
10 Year Est. Return
+496.57%
AUM
$6.61B
AUM Growth
+$398M
(+6.4%)
Cap. Flow
-$226M
Cap. Flow
% of AUM
-3.42%
Top 10 Holdings %
Top 10 Hldgs %
15.55%
Holding
1,373
New
121
Increased
405
Reduced
579
Closed
55
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EOG Resources
EOG
|
+$17.2M |
| 2 |
AEGR
Aegerion Pharmaceuticals
AEGR
|
+$14M |
| 3 |
PepsiCo
PEP
|
+$12.7M |
| 4 |
Apple
AAPL
|
+$11.7M |
| 5 |
GE Aerospace
GE
|
+$9.75M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Flowserve
FLS
|
+$13.3M |
| 2 |
Xylem
XYL
|
+$13M |
| 3 |
Microsoft
MSFT
|
+$12.4M |
| 4 |
WWAV
The WhiteWave Foods Company
WWAV
|
+$12.2M |
| 5 |
SPX Corp
SPXC
|
+$12M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.88% |
| 2 | Technology | 13.2% |
| 3 | Industrials | 12.57% |
| 4 | Financials | 12.22% |
| 5 | Consumer Staples | 9.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
iShares MSCI Emerging Markets ETF
EEM
$28.9B
| $2.35M | 0.04% |
56,170
+54,070
| +2,575% | +$2.26M |
|
477
Lam Research
LRCX
$369B
| $2.34M | 0.04% |
429,060
+206,270
| +93% | +$1.09M |
|
478
NewMarket
NEU
$7.86B
| $2.31M | 0.04% |
6,916
-10,547
| -60% | -$3.32M |
|
479
Herc Holdings
HRI
$5.48B
| $2.31M | 0.03% |
26,870
-11,130
| -29% | -$795K |
|
|
LIFE
480
DELISTED
LIFE TECHNOLOGIES CORP COM STK (DE)
LIFE
| $2.3M | 0.03% |
30,353
-9,313
| -23% | -$702K |
|
481
Wynn Resorts
WYNN
$10.2B
| $2.29M | 0.03% |
11,808
-28,179
| -70% | -$4.8M |
|
482
Equifax
EFX
$20.5B
| $2.29M | 0.03% |
33,173
+7,602
| +30% | +$494K |
|
483
Novartis
NVS
$292B
| $2.29M | 0.03% |
31,826
-13,004
| -29% | -$904K |
|
484
Omega Healthcare
OHI
$14.7B
| $2.29M | 0.03% |
76,863
+2,202
| +3% | +$69.8K |
|
485
Analog Devices
ADI
$176B
| $2.26M | 0.03% |
44,356
-6,893
| -13% | -$336K |
|
|
STJ
486
DELISTED
St Jude Medical
STJ
| $2.25M | 0.03% |
36,275
-6,658
| -16% | -$386K |
|
|
K
487
DELISTED
Kellanova
K
| $2.24M | 0.03% |
39,136
-3,835
| -9% | -$221K |
|
488
Hartford Financial Services
HIG
$39.2B
| $2.24M | 0.03% |
61,774
-4,489
| -7% | -$155K |
|
489
Sociedad Química y Minera de Chile
SQM
$19.1B
| $2.23M | 0.03% |
88,598
+52,585
| +146% | +$1.36M |
|
490
Illumina
ILMN
$29.9B
| $2.22M | 0.03% |
20,671
-1,255
| -6% | -$115K |
|
|
TAL
491
DELISTED
TAL INTERNATIONAL GROUP, INC.
TAL
| $2.21M | 0.03% |
+38,538
| New | +$1.98M |
|
492
Ecolab
ECL
$78.6B
| $2.21M | 0.03% |
21,191
-401
| -2% | -$41.7K |
|
493
Amphenol
APH
$201B
| $2.2M | 0.03% |
197,656
-56,456
| -22% | -$584K |
|
494
Banco de Chile
BCH
$21B
| $2.2M | 0.03% |
84,221
+26,687
| +46% | +$706K |
|
|
APOL
495
DELISTED
Apollo Education Group Inc Class A
APOL
| $2.19M | 0.03% |
80,239
+60,714
| +311% | +$1.51M |
|
496
Regal Rexnord
RRX
$14.1B
| $2.19M | 0.03% |
29,678
-1,920
| -6% | -$139K |
|
|
TGI
497
DELISTED
Triumph Group
TGI
| $2.19M | 0.03% |
28,762
-107,475
| -79% | -$7.79M |
|
498
Masco
MAS
$14.7B
| $2.16M | 0.03% |
107,746
+15,287
| +17% | +$284K |
|
499
Intuitive Surgical
ISRG
$133B
| $2.15M | 0.03% |
50,499
-51,093
| -50% | -$2.15M |
|
|
CBST
500
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
| $2.15M | 0.03% |
31,148
+3,963
| +15% | +$257K |
|
Similar funds
HF
KBC Group's Q4 2013 Portfolio in Review
As of Q4 2013, KBC Group held 1,373 positions worth $6.61B, up 6.4% from $6.21B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
KBC Group withdrew a net $226M in Q4 2013, closing 55 positions and reducing 579 holdings. Its most notable exit was Steris, an estimated $5.72M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Industrials.
Against the trend, KBC Group opened a new position in Aegerion Pharmaceuticals worth $13M.
- KBC Group's largest Q4 2013 buy was Aegerion Pharmaceuticals: 183,492 shares worth $13M.
- KBC Group added most to EOG Resources in Q4 2013, an estimated $17.2M increase.
- KBC Group's biggest Q4 2013 reduction was Flowserve, cutting an estimated $13.3M.
- KBC Group fully exited Steris in Q4 2013, selling an estimated $5.72M.
- KBC Group's ten largest holdings make up 16% of its $6.61B portfolio in Q4 2013.
- KBC Group opened 121 new positions and closed 55 in Q4 2013.
- KBC Group's portfolio value rose 6.4% quarter-over-quarter to $6.61B.
Based on KBC Group's 13F filing for Q4 2013, filed 21 Jan 2014.